HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extravascular lung water: effects of using ionic contrast media at varying levels of left atrial pressure and during myocardial ischemia.

Abstract
Intravenous injections of ionic contrast media are widely used in the performance of radiographic techniques. The effects of ionic contrast media on lung water are unclear in the setting of elevated left atrial pressure, particularly in the presence of myocardial ischemia. In this study, we examined the effects of bolus injections of intravenous sodium meglumine diatrizoate (Renografin 76, 1 ml/kg, injected at 20 ml per second) on measures of extravascular lung water (EVLW) at several levels of left atrial pressure and in the presence of myocardial ischemia. Bolus injections of Renografin 76 produced significant increases in EVLW, with similar mean peak increases of approximately 26% EVLW at low (initial pressure less than 3 mm Hg), moderate (approximately 15 mm Hg), and elevated left atrial pressures (approximately 25 mm Hg). At matched pressures, the peak change in EVLW in the ischemic dogs was +45%, +60%, and +70%, respectively (all P less than .001 vs. the nonischemic dogs). Thus, use of intravenous ionic media precipitated acute transient increases in lung water, which were exaggerated by myocardial ischemia. While the effects were time limited in this experimental model, caution is advised in using intravenous ionic media in patients who have left ventricular dysfunction, particularly if underlying ischemia is present.
AuthorsR A Slutsky, J J Brown, G Strich
JournalRadiology (Radiology) Vol. 152 Issue 3 Pg. 575-8 (Sep 1984) ISSN: 0033-8419 [Print] United States
PMID6379743 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Retracted Publication)
Chemical References
  • Contrast Media
  • Drug Combinations
  • Diatrizoate
  • Diatrizoate Meglumine
  • urovision
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Cardiac Catheterization
  • Cardiac Output (drug effects)
  • Contrast Media (adverse effects)
  • Coronary Disease (physiopathology)
  • Diatrizoate (adverse effects)
  • Diatrizoate Meglumine (adverse effects)
  • Dogs
  • Drug Combinations
  • Extracellular Space (drug effects)
  • Heart Atria (drug effects)
  • Hypertension (physiopathology)
  • Injections, Intravenous
  • Lung (drug effects, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: